OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value
$1.68+0.01 (+0.60%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
OPKO Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
OPKO Health's profit margin for the twelve months ending Sep 30, 2026 was -29.5%. For fiscal 2025 it was -37.2%, against -7.5% the year before. The highest annual figure on record is 2.1% in fiscal 2020.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -37.2% | −29.7 |
| FY2024 | Dec 31, 2024 | -7.5% | +14.4 |
| FY2023 | Dec 31, 2023 | -21.9% | +10.8 |
| FY2022 | Dec 31, 2022 | -32.7% | −31.0 |
| FY2021 | Dec 31, 2021 | -1.7% | −3.8 |
| FY2020 | Dec 31, 2020 | 2.1% | +37.0 |
| FY2019 | Dec 31, 2019 | -34.9% | −19.5 |
| FY2018 | Dec 31, 2018 | -15.5% | +16.1 |
| FY2017 | Dec 31, 2017 | -31.6% | −27.3 |
| FY2016 | Dec 31, 2016 | -4.3% | +1.8 |
| FY2015 | Dec 31, 2015 | -6.1% | +182.3 |
| FY2014 | Dec 31, 2014 | -188.4% | −69.9 |
| FY2013 | Dec 31, 2013 | -118.5% | −56.8 |
| FY2012 | Dec 31, 2012 | -61.7% | −57.2 |
| FY2011 | Dec 31, 2011 | -4.6% | +61.8 |
| FY2010 | Dec 31, 2010 | -66.4% | +615.2 |
| FY2009 | Dec 31, 2009 | -681.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -81.8% | −120.2 |
| Q2 FY2026 | Jun 30, 2026 | -5.1% | +89.5 |
| Q1 FY2026 | Mar 31, 2026 | -44.2% | +0.9 |
| Q4 FY2025 | Dec 31, 2025 | -21.1% | −28.7 |
| Q3 FY2025 | Sep 30, 2025 | 38.3% | +24.0 |
| Q2 FY2025 | Jun 30, 2025 | -94.7% | −89.0 |
| Q1 FY2025 | Mar 31, 2025 | -45.1% | +2.0 |
| Q4 FY2024 | Dec 31, 2024 | 7.6% | +44.2 |
| Q3 FY2024 | Sep 30, 2024 | 14.3% | +61.6 |
| Q2 FY2024 | Jun 30, 2024 | -5.7% | +1.7 |
| Q1 FY2024 | Mar 31, 2024 | -47.1% | −39.4 |
| Q4 FY2023 | Dec 31, 2023 | -36.5% | +9.4 |
| Q3 FY2023 | Sep 30, 2023 | -47.3% | +0.6 |
| Q2 FY2023 | Jun 30, 2023 | -7.4% | +25.4 |
| Q1 FY2023 | Mar 31, 2023 | -7.7% | +9.1 |
| Q4 FY2022 | Dec 31, 2022 | -46.0% | −27.6 |
| Q3 FY2022 | Sep 30, 2022 | -47.9% | −55.3 |
| Q2 FY2022 | Jun 30, 2022 | -32.8% | −29.1 |
| Q1 FY2022 | Mar 31, 2022 | -16.8% | −22.5 |
| Q4 FY2021 | Dec 31, 2021 | -18.4% | −24.9 |
| Q3 FY2021 | Sep 30, 2021 | 7.4% | +1.9 |
| Q2 FY2021 | Jun 30, 2021 | -3.7% | −14.8 |
| Q1 FY2021 | Mar 31, 2021 | 5.7% | +33.7 |
| Q4 FY2020 | Dec 31, 2020 | 6.5% | +56.6 |
| Q3 FY2020 | Sep 30, 2020 | 5.5% | +32.6 |
| Q2 FY2020 | Jun 30, 2020 | 11.2% | +37.6 |
| Q1 FY2020 | Mar 31, 2020 | -28.0% | +8.3 |
| Q4 FY2019 | Dec 31, 2019 | -50.1% | −15.8 |
| Q3 FY2019 | Sep 30, 2019 | -27.1% | −16.0 |
| Q2 FY2019 | Jun 30, 2019 | -26.4% | −24.1 |
| Q1 FY2019 | Mar 31, 2019 | -36.3% | −19.4 |
| Q4 FY2018 | Dec 31, 2018 | -34.3% | – |
| Q3 FY2018 | Sep 30, 2018 | -11.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -2.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -16.9% | – |
See a number that looks wrong?